Skip to main content
Clinical Trials/JPRN-UMIN000008151
JPRN-UMIN000008151
Completed
未知

Controlled Anti-platelet medical therapy based on rapid CYP2C19 gene evaluation in Acute myocardial infarction - CALDERA-GENE STUDY

Graduate School of Medical Sciences, Kumamoto University0 sites100 target enrollmentJune 12, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute myocardial infarction
Sponsor
Graduate School of Medical Sciences, Kumamoto University
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 12, 2012
End Date
March 27, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Graduate School of Medical Sciences, Kumamoto University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • We exclude patients with deep vein thrombosis, cerebral infarction, atrial fibrillation, collagen disease ,disseminated intravascular coagulation, sepsis, severe infection and malignant diseases. We exclude patients who were treated with warfarin, steroids, thrombolytic agents, ticlopidine, sarpogrelate or cilostazol. We exclude patients with severe liver or renal dysfunction. We exclude patients who need mechanical cardio\-plumonary supports such as intraaortic balloon pumping(IABP) or percutaneous cardiopulmonary support(PCPS).

Outcomes

Primary Outcomes

Not specified

Similar Trials